Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained ...
Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) significantly reduced nasal polyp severity, the need for subsequent surgery, and ...
Bitcoin ETFs Finally Snap Eight-Day $3.2B Outflow Streak With $94.3M Inflows
The inflows come amid a slight market recovery as BTC rebounds from its monthly low, over growing pro-crypto stance from the ...